Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT01441687
NA

Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome

Sponsor: City of Hope Medical Center

View on ClinicalTrials.gov

Summary

This randomized pilot phase I trial studies the best way, either expressed prostatic secretion (EPS) or post massage urine (PMU) biomarkers, of predicting biopsy results in patients undergoing prostate biopsy. Studying samples of urine in the laboratory may help doctors detect prostate cancer. It is not yet known whether EPS or PMU biomarkers are more effective in predicting prostate biopsy results

Key Details

Gender

MALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

243

Start Date

2009-07-14

Completion Date

2027-02-03

Last Updated

2026-03-23

Healthy Volunteers

Yes

Interventions

OTHER

laboratory biomarker analysis

Correlative studies

PROCEDURE

transrectal prostate biopsy

Undergo prostate biopsy

Locations (5)

Chinn & Chinn Urology Associates, Inc.

Arcadia, California, United States

City of Hope Medical Center

Duarte, California, United States

Citrus Valley Urologic Medical Group

Glendora, California, United States

Dr. Felix Chi-Ming Yip

Monterey Park, California, United States

City of Hope- South Pasadena Cancer Center

South Pasadena, California, United States